| pubmed-article:18214428 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:18214428 | lifeskim:mentions | umls-concept:C0034493 | lld:lifeskim |
| pubmed-article:18214428 | lifeskim:mentions | umls-concept:C0026336 | lld:lifeskim |
| pubmed-article:18214428 | lifeskim:mentions | umls-concept:C0028094 | lld:lifeskim |
| pubmed-article:18214428 | lifeskim:mentions | umls-concept:C0265110 | lld:lifeskim |
| pubmed-article:18214428 | lifeskim:mentions | umls-concept:C0549178 | lld:lifeskim |
| pubmed-article:18214428 | lifeskim:mentions | umls-concept:C1708528 | lld:lifeskim |
| pubmed-article:18214428 | lifeskim:mentions | umls-concept:C1553224 | lld:lifeskim |
| pubmed-article:18214428 | lifeskim:mentions | umls-concept:C0205421 | lld:lifeskim |
| pubmed-article:18214428 | lifeskim:mentions | umls-concept:C1515655 | lld:lifeskim |
| pubmed-article:18214428 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:18214428 | pubmed:dateCreated | 2008-4-18 | lld:pubmed |
| pubmed-article:18214428 | pubmed:abstractText | Intrathecal bolus administration of nitric oxide donors and calcium channel antagonists has been proposed to reduce cerebral vasospasm (CVS) in animal subarachnoid hemorrhage (SAH) models. Intrathecal continuous administration of these substances for CVS prevention has not been extensively evaluated. This study compared the efficacy of continuous intrathecal infusions of the NO donor glyceroltrinitrate and nimodipine in preventing delayed CVS associated with SAH in an animal model in vivo. | lld:pubmed |
| pubmed-article:18214428 | pubmed:language | eng | lld:pubmed |
| pubmed-article:18214428 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18214428 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:18214428 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18214428 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18214428 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18214428 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18214428 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:18214428 | pubmed:month | May | lld:pubmed |
| pubmed-article:18214428 | pubmed:issn | 0342-4642 | lld:pubmed |
| pubmed-article:18214428 | pubmed:author | pubmed-author:FandinoJavier... | lld:pubmed |
| pubmed-article:18214428 | pubmed:author | pubmed-author:JakobStephan... | lld:pubmed |
| pubmed-article:18214428 | pubmed:author | pubmed-author:MarbacherSerg... | lld:pubmed |
| pubmed-article:18214428 | pubmed:author | pubmed-author:Neuschmelting... | lld:pubmed |
| pubmed-article:18214428 | pubmed:author | pubmed-author:GraupnerThilo... | lld:pubmed |
| pubmed-article:18214428 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:18214428 | pubmed:volume | 34 | lld:pubmed |
| pubmed-article:18214428 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:18214428 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:18214428 | pubmed:pagination | 932-8 | lld:pubmed |
| pubmed-article:18214428 | pubmed:meshHeading | pubmed-meshheading:18214428... | lld:pubmed |
| pubmed-article:18214428 | pubmed:meshHeading | pubmed-meshheading:18214428... | lld:pubmed |
| pubmed-article:18214428 | pubmed:meshHeading | pubmed-meshheading:18214428... | lld:pubmed |
| pubmed-article:18214428 | pubmed:meshHeading | pubmed-meshheading:18214428... | lld:pubmed |
| pubmed-article:18214428 | pubmed:meshHeading | pubmed-meshheading:18214428... | lld:pubmed |
| pubmed-article:18214428 | pubmed:meshHeading | pubmed-meshheading:18214428... | lld:pubmed |
| pubmed-article:18214428 | pubmed:meshHeading | pubmed-meshheading:18214428... | lld:pubmed |
| pubmed-article:18214428 | pubmed:meshHeading | pubmed-meshheading:18214428... | lld:pubmed |
| pubmed-article:18214428 | pubmed:meshHeading | pubmed-meshheading:18214428... | lld:pubmed |
| pubmed-article:18214428 | pubmed:meshHeading | pubmed-meshheading:18214428... | lld:pubmed |
| pubmed-article:18214428 | pubmed:meshHeading | pubmed-meshheading:18214428... | lld:pubmed |
| pubmed-article:18214428 | pubmed:meshHeading | pubmed-meshheading:18214428... | lld:pubmed |
| pubmed-article:18214428 | pubmed:meshHeading | pubmed-meshheading:18214428... | lld:pubmed |
| pubmed-article:18214428 | pubmed:meshHeading | pubmed-meshheading:18214428... | lld:pubmed |
| pubmed-article:18214428 | pubmed:year | 2008 | lld:pubmed |
| pubmed-article:18214428 | pubmed:articleTitle | Prevention of delayed cerebral vasospasm by continuous intrathecal infusion of glyceroltrinitrate and nimodipine in the rabbit model in vivo. | lld:pubmed |
| pubmed-article:18214428 | pubmed:affiliation | Department of Intensive Care Medicine, University Hospital, Freiburgstrasse 10, 3010 Berne, Switzerland. | lld:pubmed |
| pubmed-article:18214428 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:18214428 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:18214428 | pubmed:publicationType | Evaluation Studies | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18214428 | lld:pubmed |
